USFDA inspection concludes at Zydus' Biologics Injectable plant, Ahmedabad

The USFDA conducted GMP surveillance Inspection for the company's Unit 9 facility located at Zydus Biotech Park, Changodar, Ahmedabad. The inspection was conducted from 27th April to 5th May 2026.

The inspection closed with seven observations. There were no data integrity related observations. The Company will closely work with the USFDA to address the observations expeditiously.

Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 939.10 as compared to the previous close of Rs. 911.85. The total number of shares traded during the day was 51160 in over 2719 trades.

The stock hit an intraday high of Rs. 943.95 and intraday low of 915.25. The net turnover during the day was Rs. 47659107.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 Pharmaceuticals Unit9 USFDA GMPSurveillanceInspection